drugset
drugset / Trial / NCT02209155

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

NCT02209155 ↗

Phase 2 Terminated 1 enrolled Center Laboratories, Inc.
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This is a double-blinded, randomized, parallel, placebo-controlled phase 2 study to evaluate the safety and efficacy of R-verapamil in the prophylaxis of episodic cluster headache.

Timeline

Start
2013-11
Primary completion
2018-03
Completion
2018-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator DEXVERAPAMIL Small molecule 75 mg —

Indications

cluster headache syndrome